دورية أكاديمية

Rituximab biosimilar RTXM83 versus reference rituximab in combination with CHOP as first-line treatment for diffuse large B-cell lymphoma: a randomized, double-blind study

التفاصيل البيبلوغرافية
العنوان: Rituximab biosimilar RTXM83 versus reference rituximab in combination with CHOP as first-line treatment for diffuse large B-cell lymphoma: a randomized, double-blind study
المؤلفون: Candelaria, Myrna, González, Derlis E., Delamain, Marcia Torresan, Bär, Daniel Oscar, Beniwal, Surender Kumar, Dasappa, Lokanatha, Flores, David Hugo, Querol, John, Guan, Toh See, Lipatov, Oleg Nikolaevich, Volodicheva, Elena Mikhailovna, Patel, Moosa, Safaee Nodehi, Sayyed Reza, Fogliatto, Laura, Paravisini, Alexandra, Perez Diaz, Luis
المساهمون: mAbxience Research S.L
المصدر: Leukemia & Lymphoma ; volume 60, issue 14, page 3375-3385 ; ISSN 1042-8194 1029-2403
بيانات النشر: Informa UK Limited
سنة النشر: 2019
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1080/10428194.2019.1633632
الإتاحة: https://doi.org/10.1080/10428194.2019.1633632Test
حقوق: http://creativecommons.org/licenses/by-nc-nd/4.0Test/
رقم الانضمام: edsbas.8B3673D4
قاعدة البيانات: BASE